WallStreetZenWallStreetZen

NASDAQ: ATYR
Atyr Pharma Inc Stock Ownership - Who owns Atyr Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atyr Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul SchimmelDirector2026-05-27100,000$0.50
$49.60kBuy
Jill Marie BroadfootChief Financial Officer2026-02-041,558$0.98
$1.52kSell
Nancy DenyesGeneral Counsel2026-02-041,118$0.98
$1.09kSell
Sanjay ShuklaPresident and CEO2026-02-043,745$0.98
$3.66kSell
Paul SchimmelDirector2025-10-09317,999$0.94
$299.24kBuy
Paul SchimmelDirector2025-10-08682,001$0.90
$612.44kBuy

1 of 1

ATYR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATYR insiders and whales buy or sell their stock.

ATYR Shareholders

What type of owners hold Atyr Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC15.00%14,706,843$7.10MInstitution
Federated Hermes Inc10.72%10,509,678$5.08MInstitution
Blackrock Inc6.57%6,443,904$3.11MInstitution
Ubs Group Ag3.94%3,867,213$1.87MInstitution
Vanguard Capital Management LLC3.89%3,812,132$1.84MInstitution
Geode Capital Management LLC2.43%2,385,485$1.15MInstitution
Sofinnova Venture Partners IX LP1.90%1,866,126$901.34kInsider
Srinivas Akkaraju1.90%1,866,126$901.34kInsider
Amir Nashat1.88%1,840,564$888.99kInsider
Polaris Venture Management Co V LLC1.86%1,827,992$882.92kInsider

1 of 3

ATYR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATYR57.17%16.45%Net BuyingNet Buying
INMB20.23%27.96%Net BuyingNet Buying
EDSA21.11%78.89%Net BuyingNet Buying
BYSI14.55%11.15%Net Selling
FLNA27.72%72.28%Net Buying
View Top Biotech Stocks

Atyr Pharma Stock Ownership FAQ

Who owns Atyr Pharma?

Atyr Pharma (NASDAQ: ATYR) is owned by 57.17% institutional shareholders, 16.45% Atyr Pharma insiders, and 26.37% retail investors. Sofinnova Venture Partners IX LP is the largest individual Atyr Pharma shareholder, owning 1.87M shares representing 1.90% of the company. Sofinnova Venture Partners IX LP's Atyr Pharma shares are currently valued at $895.74k.

If you're new to stock investing, here's how to buy Atyr Pharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.